Teva: Progressing As Expected; US Generic Revenue Reveals Strength
publication date: Jul 31, 2014
The generics pharma giant has been one of the best performing stocks during 2014, up nearly 34% year-to-date.
To gain access to the members only content, click here to subscribe. You will be given immediate access to premium content on the site.